New Amsterdam Pharma
Wouter Joustra is a General Partner at Forbion and joined the company in 2019 to co-launch Forbion’s Growth Opportunities Fund. Previously, Wouter was a Senior Trader Life Sciences at Kempen, one of the leading European investment banks focused on Life Sciences & Healthcare. In this role, Wouter ran Kempen’s Life Sciences portfolio and was involved in deal structuring and equity capital market transactions. Wouter also served as an Executive Board member of Kempen’s Life Sciences Franchise. As part of his portfolio at Forbion, Wouter currently serves as a board member at Gyroscope Therapeutics.
This person is not in the org chart
This person is not in any offices
New Amsterdam Pharma
1 followers
Founded in 2019 by the venture capital firm Forbion and John Kastelein, NewAmsterdam Pharma is a privately held, clinical-stage company focused on the research and development of transformative therapies for cardiometabolic diseases. Its mission is to improve patient care in populations where traditional therapies are not tolerated or have been unsuccessful.